Evidence map›Paper›PMID 27821709›Full record

ArticleToxicologic pathology2017

Proceedings of the 2016 National Toxicology Program Satellite Symposium.

Susan A Elmore, Vivian S Chen, Schantel Hayes-Bouknight, Jessica S Hoane, Kyathanahalli Janardhan, Linda H Kooistra, Thomas Nolte, Kathleen A Szabo, Gabrielle A Willson, Jeffrey C Wolf and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Toxicologic pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Susan A Elmore1 National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.
Vivian S Chen2 Charles River Laboratories, Inc., Durham, North Carolina, USA.
Schantel Hayes-Bouknight2 Charles River Laboratories, Inc., Durham, North Carolina, USA.
Jessica S Hoane2 Charles River Laboratories, Inc., Durham, North Carolina, USA.
Kyathanahalli Janardhan3 Integrated Laboratory Systems, Inc., Research Triangle Park, North Carolina, USA.
Linda H Kooistra2 Charles River Laboratories, Inc., Durham, North Carolina, USA.
Thomas Nolte4 Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
Kathleen A Szabo2 Charles River Laboratories, Inc., Durham, North Carolina, USA.
Gabrielle A Willson5 Experimental Pathology Laboratories, Inc., Research Triangle Park, North Carolina, USA.
Jeffrey C Wolf6 Experimental Pathology Laboratories, Inc., Sterling, Virginia, USA.
David E Malarkey1 National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.
Charles River Laboratories (United States) · USExperimental Pathology Laboratories · USNational Institute of Environmental Health Sciences · USBoehringer Ingelheim (Germany) · DEIntegrated Laboratory Systems, Inc. · US

Funding

Toxicologic Pathology Evaluations for the National Toxicology ProgramZIAES103319 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI MALARKEY, DAVID · 2016 to 2019
$25.2M
Intramural NIH HHS Z99 ES999999
6 · The paper itself

Abstract

The 2016 annual National Toxicology Program Satellite Symposium, entitled "Pathology Potpourri" was held in San Diego, CA, at the Society of Toxicologic Pathology's (STP) 35th annual meeting. The goal of this symposium was to present and discuss challenging diagnostic pathology and/or nomenclature issues. This article presents summaries of the speakers' talks, along with select images that were used by the audience for voting and discussion. Some lesions and topics covered during the symposium included malignant glioma and histiocytic sarcoma in the rodent brain; a new statistical method designed for histopathology data evaluation; uterine stromal/glandular polyp in a rat; malignant plasma cell tumor in a mouse brain; Schwann cell proliferative lesions in rat hearts; axillary schwannoma in a cat; necrosis and granulomatous inflammation in a rat brain; adenoma/carcinoma in a rat adrenal gland; hepatocyte maturation defect and liver/spleen hematopoietic defects in an embryonic mouse; distinguishing malignant glioma, malignant mixed glioma, and malignant oligodendroglioma in the rat; comparison of mammary gland whole mounts and histopathology from mice; and discussion of the International Harmonization of Nomenclature and Diagnostic Criteria collaborations.

Indexed as

PathologyToxicologyAnimalsCongresses as TopicDiagnostic Techniques and ProceduresHumansTerminology as Topicabnormal mouse fetal developmentadrenal gland carcinomabrain plasma cell tumorendometrial polypglioblastoma multiformeINHANDmalignant gliomamammary gland whole mountNTP Satellite SymposiumRao-Scott Cochran-Armitage by Slicesschwannoma

Identifiers

PMID27821709
PMCPMC5225145
OpenAlexW2915500125

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.